Evaluating the progenitor cells of ovarian cancer: Analysis of current animal models

BMB Reports

Volumn 44, Issue 7, 2011, Pages 435-445

  King, Shelby M ^a   Burdette, Joanna E ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Animal model; Fallopian tube epithelium; Ovarian surface epithelium; Ovulation; Serous ovarian cancer

Indexed keywords

ANIMAL; ANIMAL MODEL; CANCER STEM CELL; EPITHELIUM; EVALUATION; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; METABOLISM; OVARY TUMOR; PATHOLOGY; SHORT SURVEY;

ANIMALS; EPITHELIUM; EVALUATION STUDIES AS TOPIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, ANIMAL; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS;

ANIMALIA;

EID: 79961047341     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2011.44.7.435     Document Type: Short Survey

References (89)

1. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J. and Thun, M. J. (2009) Cancer statistics, 2009. CA Cancer. J. Clin. 59, 225-249.
2. Auersperg, N., Maines-Bandiera, S. L. and Dyck, H. G. (1997) Ovarian carcinogenesis and the biology of ovarian surface epithelium. J. Cell. Physiol. 173, 261-265.
3. Bell, D. A. (2005) Origins and molecular pathology of ovarian cancer. Mod. Pathol. 18 (Suppl 2), S19-32.
4. Gilks, C. B. (2010) Molecular abnormalities in ovarian cancer subtypes other than high-grade serous carcinoma. J. Oncol. 2010, 740968.
5. Shih Ie, M. and Kurman, R. J. (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am. J. Pathol. 164, 1511-1518.
6. Auersperg, N., Ota, T. and Mitchell, G. W. (2002) Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches. Int. J. Gynecol. Cancer 12, 691-703.
7. Scully, R. E. (1995) Early de novo ovarian cancer and cancer developing in benign ovarian lesions. Int. J. Gynaecol. Obstet. 49 (Suppl), S9-15.
8. Lee, Y., Miron, A., Drapkin, R., Nucci, M. R., Medeiros, F., Saleemuddin, A., Garber, J., Birch, C., Mou, H., Gordon, R. W., Cramer, D. W., McKeon, F. D. and Crum, C. P. (2007) A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J. Pathol. 211, 26-35.
9. Auersperg, N., Wong, A. S., Choi, K. C., Kang, S. K. and Leung, P. C. (2001) Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr. Rev. 22, 255-288.
10. Burdette, J. E., Kurley, S. J., Kilen, S. M., Mayo, K. E. and Woodruff, T. K. (2006) Gonadotropin-induced superovulation drives ovarian surface epithelia proliferation in CD1 mice. Endocrinology 147, 2338-2345.
11. Auersperg, N., Woo, M. M. and Gilks, C. B. (2008) The origin of ovarian carcinomas: a developmental view. Gynecol. Oncol. 110, 452-454.
12. Fathalla, M. F. (1971) Incessant ovulation--a factor in ovarian neoplasia? Lancet 2, 163.
13. Wright, J. W., Pejovic, T., Fanton, J. and Stouffer, R. L. (2008) Induction of proliferation in the primate ovarian surface epithelium in vivo. Hum. Reprod. 23, 129-138.
14. Parrott, J. A., Doraiswamy, V., Kim, G., Mosher, R. and Skinner, M. K. (2001) Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer. Mol. Cell Endocrinol. 172, 213-222.
15. Konishi, I., Kuroda, H. and Mandai, M. (1999) Review: gonadotropins and development of ovarian cancer. Oncology 57 (Suppl 2), 45-48.
16. Edmondson, R. J., Monaghan, J. M. and Davies, B. R. (2006) Gonadotropins mediate DNA synthesis and protection from spontaneous cell death in human ovarian surface epithelium. Int. J. Gynecol. Cancer 16, 171-177.
17. Chakravarti, S., Collins, W. P., Forecast, J. D., Newton, J. R., Oram, D. H. and Studd, J. W. (1976) Hormonal profiles after the menopause. Br. Med. J. 2, 784-787.
18. Espey, L. L. (1994) Current status of the hypothesis that mammalian ovulation is comparable to an inflammatory reaction. Biol. Reprod. 50, 233-238.
19. Murdoch, W. J. (2008) Ovulatory factor in ovarian carcinogenesis. Adv. Exp. Med. Biol. 622, 119-128.
20. Murdoch, W. J., Townsend, R. S. and McDonnel, A. C. (2001) Ovulation-induced DNA damage in ovarian surface epithelial cells of ewes: prospective regulatory mechanisms of repair/survival and apoptosis. Biol. Reprod. 65, 1417-1424.
21. Burdette, J. E., Oliver, R. M., Ulyanov, V., Kilen, S. M., Mayo, K. E. and Woodruff, T. K. (2007) Ovarian epithelial inclusion cysts in chronically superovulated CD1 and Smad2 dominant-negative mice. Endocrinology 148, 3595-3604.
22. Ghahremani, M., Foghi, A. and Dorrington, J. H. (1999) Etiology of ovarian cancer: a proposed mechanism. Med. Hypotheses 52, 23-26.
23. Roh, M. H., Kindelberger, D. and Crum, C. P. (2009) Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin? Am. J. Surg.Pathol. 33, 376-383.
24. Jarboe, E., Folkins, A., Nucci, M. R., Kindelberger, D., Drapkin, R., Miron, A., Lee, Y. and Crum, C. P. (2008) Serous carcinogenesis in the fallopian tube: a descriptive classification. Int. J. Gynecol. Pathol. 27, 1-9.
25. Kindelberger, D. W., Lee, Y., Miron, A., Hirsch, M. S., Feltmate, C., Medeiros, F., Callahan, M. J., Garner, E. O., Gordon, R. W., Birch, C., Berkowitz, R. S., Muto, M. G. and Crum, C. P. (2007) Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Am. J. Surg. Pathol. 31, 161-169.
26. Sundfeldt, K., Piontkewitz, Y., Ivarsson, K., Nilsson, O., Hellberg, P., Brannstrom, M., Janson, P. O., Enerback, S. and Hedin, L. (1997) E-cadherin expression in human epithelial ovarian cancer and normal ovary. Int. J. Cancer 74, 275-280.
27. Levanon, K., Ng, V., Piao, H. Y., Zhang, Y., Chang, M. C., Roh, M. H., Kindelberger, D. W., Hirsch, M. S., Crum, C. P., Marto, J. A. and Drapkin, R. (2010) Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis. Oncogene 29, 1103-1113.
28. Kurman, R. J. and Shih Ie, M. (2010) The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am. J. Surg. Pathol. 34, 433-443.
29. Auersperg, N. (2011) The origin of ovarian carcinomas: a unifying hypothesis. Int. J. Gynecol. Pathol. 30, 12-21.
30. Crum, C. P., Drapkin, R., Kindelberger, D., Medeiros, F., Miron, A. and Lee, Y. (2007) Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin. Med. Res. 5, 35-44.
31. Press, J. Z., De Luca, A., Boyd, N., Young, S., Troussard, A., Ridge, Y., Kaurah, P., Kalloger, S. E., Blood, K. A., Smith, M., Spellman, P. T., Wang, Y., Miller, D. M., Horsman, D., Faham, M., Gilks, C. B., Gray, J. and Huntsman, D. G. (2008) Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities. BMC Cancer 8, 17.
32. Press, J. Z., Wurz, K., Norquist, B. M., Lee, M. K., Pennil, C., Garcia, R., Welcsh, P., Goff, B. A. and Swisher, E. M. (2010) Identification of a preneoplastic gene expression profile in tubal epithelium of BRCA1 mutation carriers. Neoplasia 12, 993-1002.
33. Cass, I., Holschneider, C., Datta, N., Barbuto, D., Walts, A. E. and Karlan, B. Y. (2005) BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype? Obstet. Gynecol. 106, 1327-1334.
34. Xian, W., Miron, A., Roh, M., Semmel, D. R., Yassin, Y., Garber, J., Oliva, E., Goodman, A., Mehra, K., Berkowitz, R. S., Crum, C. P. and Quade, B. J. (2010) The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube. J. Pathol. 220, 17-23.
35. Alexander, B. M., Van Kirk, E. A., Naughton, L. M. and Murdoch, W. J. (2007) Ovarian morphometrics in TP53-deficient mice. Anat. Rec. (Hoboken) 290, 59-64.
36. Cooper, T. K. and Gabrielson, K. L. (2007) Spontaneous lesions in the reproductive tract and mammary gland of female non-human primates. Birth Defects Res. B. Dev. Reprod. Toxicol. 80, 149-170.
37. Marr-Belvin, A. K., Bailey, C. C., Knight, H. L., Klumpp, S. A., Westmoreland, S. V. and Miller, A. D. (2010) Ovarian pathology in rhesus macaques: a 12-year retrospective. J. Med. Primatol. 39, 170-176.
38. Moore, C. M., Hubbard, G. B., Leland, M. M., Dunn, B. G. and Best, R. G. (2003) Spontaneous ovarian tumors in twelve baboons: a review of ovarian neoplasms in non-human primates. J. Med. Primatol. 32, 48-56.
39. Swisher, E. (2003) Ovarian cancer associated with inherited mutations in BRCA1 or BRCA2. Curr. Womens Health Rep. 3, 27-32.
40. Cline, J. M., Wood, C. E., Vidal, J. D., Tarara, R. P., Buse, E., Weinbauer, G. F., de Rijk, E. P. and van Esch, E. (2008) Selected background findings and interpretation of common lesions in the female reproductive system in macaques. Toxicol. Pathol. 36, 142s-163s.
41. Rodriguez, G. C., Nagarsheth, N. P., Lee, K. L., Bentley, R. C., Walmer, D. K., Cline, M., Whitaker, R. S., Isner, P., Berchuck, A., Dodge, R. K. and Hughes, C. L. (2002) Progestin-induced apoptosis in the Macaque ovarian epithelium: differential regulation of transforming growth factor-beta. J. Natl. Cancer Inst. 94, 50-60.
42. Rodriguez, G. C., Walmer, D. K., Cline, M., Krigman, H., Lessey, B. A., Whitaker, R. S., Dodge, R. and Hughes, C. L. (1998) Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis? J. Soc. Gynecol. Investig. 5, 271-276.
43. Lu, K. H., Yates, M. S. and Mok, S. C. (2009) The monkey, the hen, and the mouse: models to advance ovarian cancer chemoprevention. Cancer Prev. Res. (Phila Pa) 2, 773-775.
44. Barnes, M. N., Berry, W. D., Straughn, J. M., Kirby, T. O., Leath, C. A., Huh, W. K., Grizzle, W. E. and Partridge, E. E. (2002) A pilot study of ovarian cancer chemoprevention using medroxyprogesterone acetate in an avian model of spontaneous ovarian carcinogenesis. Gynecol. Oncol. 87, 57-63.
45. Fredrickson, T. N. (1987) Ovarian tumors of the hen. Environ. Health Perspect 73, 35-51.
46. Barua, A., Bitterman, P., Abramowicz, J. S., Dirks, A. L., Bahr, J. M., Hales, D. B., Bradaric, M. J., Edassery, S. L., Rotmensch, J. and Luborsky, J. L. (2009) Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer. Int. J. Gynecol. Cancer 19, 531-539.
47. Hakim, A. A., Barry, C. P., Barnes, H. J., Anderson, K. E., Petitte, J., Whitaker, R., Lancaster, J. M., Wenham, R. M., Carver, D. K., Turbov, J., Berchuck, A., Kopelovich, L. and Rodriguez, G. C. (2009) Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu. Cancer Prev. Res. (Phila) 2, 114-121.
48. Nofech-Mozes, S., Khalifa, M. A., Ismiil, N., Saad, R. S., Hanna, W. M., Covens, A. and Ghorab, Z. (2008) Immunophenotyping of serous carcinoma of the female genital tract. Mod. Pathol. 21, 1147-1155.
49. Nowee, M. E., Dorsman, J. C., Piek, J. M., Kosma, V. M., Hamalainen, K., Verheijen, R. H. and van Diest, P. J. (2007) HER-2/neu and p27Kip1 in progression of Fallopian tube carcinoma: an immunohistochemical and array comparative genomic hybridization study. Histopathology 51, 666-673.
50. Trevino, L. S., Giles, J. R., Wang, W., Urick, M. E. and Johnson, P. A. (2010) Gene Expression Profiling Reveals Differentially Expressed Genes in Ovarian Cancer of the Hen: Support for Oviductal Origin? Hormones and Cancer 1, 177-186.
51. Greenacre, C. B. (2004) Spontaneous tumors of small mammals. Vet. Clin. North. Am. Exot. Anim. Pract. 7, 627- 651, vi.
52. Gregson, R. L., Lewis, D. J. and Abbott, D. P. (1984) Spontaneous ovarian neoplasms of the laboratory rat. Vet. Pathol. 21, 292-299.
53. Sharrow, A. C., Ronnett, B. M., Thoburn, C. J., Barber, J. P., Giuntoli, R. L., 2nd, Armstrong, D. K., Jones, R. J. and Hess, A. D. (2010) Identification and characterization of a spontaneous ovarian carcinoma in Lewis rats. J. Ovarian Res. 3, 9.
54. Komatsu, M. and Fujita, H. (1978) Electron-microscopic studies on the development and aging of the oviduct epithelium of mice. Anat. Embryol. (Berl) 152, 243-259.
55. Critoph, F. N. and Dennis, K. J. (1977) The cellular composition of the human oviduct epithelium. Br. J. Obstet. Gynaecol. 84, 219-221.
56. Baird, D. T., Baker, T. G., McNatty, K. P. and Neal, P. (1975) Relationship between the secretion of the corpus luteum and the length of the follicular phase of the ovarian cycle. J. Reprod. Fertil. 45, 611-619.
57. Maronpot, R. R. (1987) Ovarian toxicity and carcinogenicity in eight recent National Toxicology Program studies. Environ. Health Perspect 73, 125-130.
58. Bai, W., Oliveros-Saunders, B., Wang, Q., Acevedo-Duncan, M. E. and Nicosia, S. V. (2000) Estrogen stimulation of ovarian surface epithelial cell proliferation. In Vitro Cell Dev. Biol. Anim. 36, 657-666.
59. Umezu, T., Hanazono, M., Aizawa, S. and Tomooka, Y. (2003) Characterization of newly established clonal oviductal cell lines and differential hormonal regulation of gene expression. In Vitro Cell Dev. Biol. Anim. 39, 146-156.
60. Ziecik, A. J., Kaczmarek, M. M., Blitek, A., Kowalczyk, A. E., Li, X. and Rahman, N. A. (2007) Novel biological and possible applicable roles of LH/hCG receptor. Mol. Cell. Endocrinol. 269, 51-60.
61. Tunca, J. C., Erturk, E. and Bryan, G. T. (1985) Chemical induction of ovarian tumors in rats. Gynecol. Oncol. 21, 54-64.
62. Stewart, S. L., Querec, T. D., Ochman, A. R., Gruver, B. N., Bao, R., Babb, J. S., Wong, T. S., Koutroukides, T., Pinnola, A. D., Klein-Szanto, A., Hamilton, T. C. and Patriotis, C. (2004) Characterization of a carcinogenesis rat model of ovarian preneoplasia and neoplasia. Cancer Res. 64, 8177-8183.
63. Crist, K. A., Zhang, Z., You, M., Gunning, W. T., Conran, P. B., Steele, V. E. and Lubet, R. A. (2005) Characterization of rat ovarian adenocarcinomas developed in response to direct instillation of 7,12-dimethylbenz[a]anthracene (DMBA) coated suture. Carcinogenesis 26, 951-957.
64. Wang, Y., Zhang, Z., Lu, Y., Yao, R., Jia, D., Wen, W., LaRegina, M., Crist, K., Lubet, R. and You, M. (2008) Enhanced susceptibility to chemical induction of ovarian tumors in mice with a germ line p53 mutation. Mol. Cancer Res. 6, 99-109.
65. Jarboe, E. A., Pizer, E. S., Miron, A., Monte, N., Mutter, G. L. and Crum, C. P. (2009) Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma. Mod. Pathol. 22, 345-350.
66. Corney, D. C., Flesken-Nikitin, A., Choi, J. and Nikitin, A. Y. (2008) Role of p53 and Rb in ovarian cancer. Adv. Exp. Med. Biol. 622, 99-117.
67. Gowen, L. C., Johnson, B. L., Latour, A. M., Sulik, K. K. and Koller, B. H. (1996) Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat. Genet. 12, 191-194.
68. Garson, K., Shaw, T. J., Clark, K. V., Yao, D. S. and Vanderhyden, B. C. (2005) Models of ovarian cancer-are we there yet? Mol. Cell Endocrinol. 239, 15-26.
69. Boyd, J. (2005) Mouse models of gynecologic pathology. N. Engl. J. Med. 352, 2240-2242.
70. Buller, R. E., Lallas, T. A., Shahin, M. S., Sood, A. K., Hatterman-Zogg, M., Anderson, B., Sorosky, J. I. and Kirby, P. A. (2001) The p53 mutational spectrum associated with BRCA1 mutant ovarian cancer. Clin Cancer Res. 7, 831-838.
71. Clark-Knowles, K. V., Senterman, M. K., Collins, O. and Vanderhyden, B. C. (2009) Conditional inactivation of Brca1, p53 and Rb in mouse ovaries results in the development of leiomyosarcomas. PLoS One 4, e8534.
72. Clark-Knowles, K. V., Garson, K., Jonkers, J. and Vanderhyden, B. C. (2007) Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes. Exp. Cell Res. 313, 133-145.
73. Quinn, B. A., Brake, T., Hua, X., Baxter-Jones, K., Litwin, S., Ellenson, L. H. and Connolly, D. C. (2009) Induction of ovarian leiomyosarcomas in mice by conditional inactivation of Brca1 and p53. PLoS One 4, e8404.
74. Flesken-Nikitin, A., Choi, K. C., Eng, J. P., Shmidt, E. N. and Nikitin, A. Y. (2003) Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium. Cancer Res. 63, 3459-3463.
75. Laviolette, L. A., Garson, K., Macdonald, E. A., Senterman, M. K., Courville, K., Crane, C. A. and Vanderhyden, B. C. (2010) 17beta-estradiol accelerates tumor onset and decreases survival in a transgenic mouse model of ovarian cancer. Endocrinology 151, 929-938.
76. Tanyi, J. L., Lapushin, R., Eder, A., Auersperg, N., Tabassam, F. H., Roth, J. A., Gu, J., Fang, B., Mills, G. B. and Wolf, J. (2002) Identification of tissue- and cancer-selective promoters for the introduction of genes into human ovarian cancer cells. Gynecol. Oncol. 85, 451-458.
77. Zhang, Y., Huang, G., Shornick, L. P., Roswit, W. T., Shipley, J. M., Brody, S. L. and Holtzman, M. J. (2007) A transgenic FOXJ1-Cre system for gene inactivation in ciliated epithelial cells. Am. J. Respir. Cell Mol. Biol. 36, 515-519.
78. Miyoshi, I., Takahashi, K., Kon, Y., Okamura, T., Mototani, Y., Araki, Y. and Kasai, N. (2002) Mouse transgenic for murine oviduct-specific glycoprotein promoter-driven Simian Virus 40 large T-antigen: tumor formation and its hormonal regulation. Mol. Reprod. Dev. 63, 168-176.
79. Connolly, D. C., Bao, R., Nikitin, A. Y., Stephens, K. C., Poole, T. W., Hua, X., Harris, S. S., Vanderhyden, B. C. and Hamilton, T. C. (2003) Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res. 63, 1389-1397.
80. Quinn, B. A., Xiao, F., Bickel, L., Martin, L., Hua, X., Klein-Szanto, A. and Connolly, D. C. (2010) Development of a syngeneic mouse model of epithelial ovarian cancer. J. Ovarian Res. 3, 24.
81. Karst, A. M., Levanon, K. and Drapkin, R. (2011) Modeling high-grade serous ovarian carcinogenesis from the fallopian tube. Proc. Natl. Acad. Sci. U.S.A. 108, 7547-7552.
82. Chodankar, R., Kwang, S., Sangiorgi, F., Hong, H., Yen, H. Y., Deng, C., Pike, M. C., Shuler, C. F., Maxson, R. and Dubeau, L. (2005) Cell-nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional Brca1 in ovarian granulosa cells. Curr. Biol. 15, 561-565.
83. Zheng, W., Magid, M. S., Kramer, E. E. and Chen, Y. T. (1996) Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube. Am. J. Pathol. 148, 47-53.
84. Mishina, Y., Whitworth, D. J., Racine, C. and Behringer, R. R. (1999) High specificity of Mullerian-inhibiting substance signaling in vivo. Endocrinology 140, 2084-2088.
85. Bristol-Gould, S. K., Hutten, C. G., Sturgis, C., Kilen, S. M., Mayo, K. E. and Woodruff, T. K. (2005) The development of a mouse model of ovarian endosalpingiosis. Endocrinology 146, 5228-5236.
86. Liang, S., Yang, N., Pan, Y., Deng, S., Lin, X., Yang, X., Katsaros, D., Roby, K. F., Hamilton, T. C., Connolly, D. C., Coukos, G. and Zhang, L. (2009) Expression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formation. PLoS One 4, e4295.
87. Mullany, L. K., Fan, H. Y., Liu, Z., White, L. D., Marshall, A., Gunaratne, P., Anderson, M. L., Creighton, C. J., Xin, L., Deavers, M., Wong, K. K. and Richards, J. S. (2011) Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo. Oncogene.
88. Shayesteh, L., Lu, Y., Kuo, W. L., Baldocchi, R., Godfrey, T., Collins, C., Pinkel, D., Powell, B., Mills, G. B. and Gray, J. W. (1999) PIK3CA is implicated as an oncogene in ovarian cancer. Nat. Genet. 21, 99-102.
89. Dinulescu, D. M., Ince, T. A., Quade, B. J., Shafer, S. A., Crowley, D. and Jacks, T. (2005) Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat. Med. 11, 63-70.